
Exeliom Biosciences
Exeliom Biosciences is a biotech company in Dijon, France, founded in 2016. It has raised $37.6M across 2 rounds, most recently a $26.0M Series A in June 2023.
Crossing the next frontier, to give you a fair chance to fight
- Headquarters
- Dijon
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- exeliombio.com
- Total Funding
- $37.6M
- Last Round
- $26.0M Series AJun 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation, with a lead candidate EXL01 — a first-in-class innate immune conditioner derived from Faecalibacterium prausnitzii that targets the NOD2-CARD9 pathway to restore myeloid support for anti-tumor immunity. Founded in 2016 and headquartered in Dijon, France, the company has progressed EXL01 from discovery through multiple Phase 2 randomized clinical trials spanning gastric cancer, renal cell carcinoma, Crohn's disease, and recurrent C. difficile infections. Built on a capital-efficient model with a core team of approximately 10 employees, Exeliom has earned Bpifrance 'Deeptech' and 'I-Lab' designations as well as EIC Accelerator funding from the European Innovation Council.
Summary
It lists 1–10 employees. It has raised $37.6M in total across 2 rounds, most recently a $26.0M Series A round in Jun 2023. Investors include Crescent Enterprises, Auriga and UI Investissement.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2023
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/exeliom-biosciences"><img src="https://indexed.vc/api/badge/company/exeliom-biosciences" alt="Exeliom Biosciences on Indexed.vc" width="260" height="76" /></a>